NCT07109414
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07109414
Title Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)
Acronym ULTIMUS-1
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Novita Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Cancer Care RECRUITING Phoenix Arizona 85016 United States Details
Trials365 RECRUITING Shreveport Louisiana 71133 United States Details
University of Pennsylvania Health System, Perelman Center for Advanced Medicine RECRUITING Philadelphia Pennsylvania 19104-5127 United States Details
Utah Cancer Specialists RECRUITING Salt Lake City Utah 84106 United States Details
University Of Wisconsin Carbone Cancer Center RECRUITING Madison Wisconsin 53792-9988 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field